CVS Caremark to cover Foundayo, Zepbound obesity drugs
CVS Caremark will start covering Eli Lilly's Foundayo and resume covering its Zepbound obesity drugs in the next several months, the companies said.
America Forever Bytes
Zepbound · AFBytes
Other
Zepbound
Recent coverage
CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans
CVS will add Zepbound coverage on Oct. 1, and start covering Lilly's newly approved Foundayo pill on June 1.
CVS Caremark will cover Lilly’s weight loss drug Zepbound once again
CVS Caremark will resume covering the weight loss drug Zepbound this year after it removed it from its list of covered medications last year, drugmaker Eli Lill...